FIELD: medicine, steroid chemistry, contraceptives. SUBSTANCE: invention relates to compositions for local administration and forms for subcutaneous incorporation. These implants involve an effective dose of derivative of 3,20-dioxo-6-methyl,17-acetoxy-19-norpregna-4,6-diene substituted at 3 and/or 17 position at random and bound or mixed with biologically acceptable inert carrier. These compositions are effective contraceptive agents exhibiting the prolonged active effect, at least, for one year at minimal adverse effects. EFFECT: enhanced effectiveness of new compositions. 4 cl, 3 tbl, 5 dwg
Authors
Dates
1998-10-27—Published
1993-09-17—Filed